No Data
No Data
CASI Pharmaceuticals (NASDAQ:CASI) Shareholders Are Still up 129% Over 1 Year Despite Pulling Back 22% in the Past Week
Express News | CASI Pharmaceuticals Inc - Effective From Sept 10, Position of President of Co Was Removed
Novartis Expands U.S. Radiopharma Production Amid Rising Competition
Casi Pharmaceuticals Files to Sell 3M Ordinary Shares for Holders.
CASI Pharmaceuticals Shifts Focus, Garners Investment
CASI Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)
eternityawaits : Thanks been waiting for this!
Stock_Drift OP eternityawaits : I have $Innovative Eyewear (LUCY.US)$ and $Clearmind Medicine (CMND.US)$ waiting for some action.
eternityawaits : Nice!
let it squeeze : let her run
73282684 : you forgot ffie